Controversy and debate on dengue vaccine series-paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs
J Clin Epidemiol
.
2018 Mar:95:142.
doi: 10.1016/j.jclinepi.2017.12.025.
Epub 2018 Jan 3.
Authors
Antonio L Dans
1
,
Leonila F Dans
2
,
Mary Ann D Lansang
1
,
Maria Asuncion A Silvestre
3
,
Gordon H Guyatt
4
Affiliations
1
College of Medicine, University of the Philippines, Manila, Philippines.
2
College of Medicine, University of the Philippines, Manila, Philippines. Electronic address: leonila.dans@gmail.com.
3
Asia-Pacific Center for Evidence-Based Healthcare, Manila, Philippines.
4
McMaster University, Hamilton, Ontario, Canada.
PMID:
29306065
DOI:
10.1016/j.jclinepi.2017.12.025
No abstract available
Publication types
Comment
MeSH terms
Dengue Vaccines*
Dengue*
Humans
Mass Vaccination
Substances
Dengue Vaccines